Skip to main
RNAZ
RNAZ logo

TransCode Therapeutics (RNAZ) Market Capitalization Overview

Market Cap: $5.82M as of Jun 13, 2025

$5.82M
Past Month-$566.90K (8.89%)
As of Jun 13, 2025, TransCode Therapeutics (RNAZ) has a market capitalization of $5.82M. Over the past 30 days, its market cap has decreased by -55.1%, while in the last 12 months, it has increased by 67.54%.

Market capitalization represents the total value of TransCode Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

TransCode Therapeutics (RNAZ) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of TransCode Therapeutics (RNAZ) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

TransCode Therapeutics (RNAZ) Market Cap History

DateMarket CapChange
Jun 2, 2025$5.92M-55.10%
May 1, 2025$13.17M+4.27%
Apr 1, 2025$12.63M+538.96%
Mar 3, 2025$1.98M-74.40%
Feb 3, 2025$7.72M+112.46%
Jan 2, 2025$3.64M-25.68%

TransCode Therapeutics (RNAZ) End of Year Market Cap History

DateMarket CapChange
2025$5.82M+67.54%
2024$3.47M+96.91%
2023$1.77M-79.83%
2022$8.74M-73.35%
2021$32.78M

FAQs About TransCode Therapeutics (RNAZ) Market Cap

As of Jun 13, 2025, the market capitalization of TransCode Therapeutics (RNAZ) is $5.82M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, TransCode Therapeutics’s market capitalization has decreased by -8.89%, changing from $6.38M to $5.82M as of Jun 13, 2025.

In the last 3 months, TransCode Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, TransCode Therapeutics’s market capitalization increased from $1.77M in January to $3.47M in December, reflecting a 96.91% change.

In the past five years, TransCode Therapeutics (RNAZ) has had a compound annual growth rate (CAGR) of -42.97% in market capitalization. This means its market cap has shrunk at an average rate of -42.97% per year.

TransCode Therapeutics (RNAZ)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.